Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,000
Closed -$1.02M 5358
2024
Q3
$1.02M Hold
25,000
﹤0.01% 3348
2024
Q2
$963K Buy
+25,000
New +$1.05M ﹤0.01% 2619
2023
Q1
Sell
-201,200
Closed -$7.07M 5188
2022
Q4
$7.07M Buy
+201,200
New +$6.7M ﹤0.01% 1398
2021
Q1
Sell
-1,040
Closed -$48K 4894
2020
Q4
$48K Sell
1,040
-240
-19% -$11K ﹤0.01% 4422
2020
Q3
$60K Sell
1,280
-3,200
-71% -$160K ﹤0.01% 4503
2020
Q2
$228K Sell
4,480
-51,360
-92% -$2.63M ﹤0.01% 3965
2020
Q1
$2.65M Sell
55,840
-34,320
-38% -$1.83M ﹤0.01% 2026
2019
Q4
$5.3M Sell
90,160
-12,400
-12% -$690K ﹤0.01% 1942
2019
Q3
$5.47M Sell
102,560
-11,520
-10% -$593K ﹤0.01% 1771
2019
Q2
$5.71M Buy
114,080
+67,440
+145% +$3.38M ﹤0.01% 1748
2019
Q1
$2.44M Sell
46,640
-63,360
-58% -$3.17M ﹤0.01% 2361
2018
Q4
$5.25M Buy
110,000
+1,360
+1% +$67K ﹤0.01% 1564
2018
Q3
$5.46M Sell
108,640
-30,720
-22% -$1.56M ﹤0.01% 1727
2018
Q2
$7.02M Sell
139,360
-69,280
-33% -$3.49M 0.01% 1469
2018
Q1
$10.2M Buy
208,640
+114,320
+121% +$5.32M 0.01% 1171
2017
Q4
$4.18M Sell
94,320
-50,560
-35% -$2.34M ﹤0.01% 1804
2017
Q3
$7.35M Sell
144,880
-2,080
-1% -$106K 0.01% 1249
2017
Q2
$7.92M Buy
146,960
+90,560
+161% +$4.83M 0.01% 1128
2017
Q1
$2.97M Sell
56,400
-66,400
-54% -$3.37M ﹤0.01% 1721
2016
Q4
$5.91M Buy
122,800
+25,840
+27% +$1.28M 0.01% 1288
2016
Q3
$5.23M Sell
96,960
-10,800
-10% -$592K 0.01% 1256
2016
Q2
$5.84M Buy
107,760
+39,840
+59% +$2.1M 0.01% 1194
2016
Q1
$3.4M Buy
67,920
+6,880
+11% +$343K 0.01% 1477
2015
Q4
$3.05M Sell
61,040
-7,680
-11% -$391K ﹤0.01% 1693
2015
Q3
$3.26M Sell
68,720
-7,360
-10% -$383K ﹤0.01% 1687
2015
Q2
$3.9M Sell
76,080
-140,640
-65% -$7.92M ﹤0.01% 1699
2015
Q1
$12.5M Buy
216,720
+150,640
+228% +$8.64M 0.01% 950
2014
Q4
$3.47M Buy
66,080
+29,280
+80% +$1.64M ﹤0.01% 2021
2014
Q3
$2.07M Sell
36,800
-35,280
-49% -$2.16M ﹤0.01% 2633
2014
Q2
$4.78M Buy
72,080
+7,680
+12% +$520K 0.01% 1797
2014
Q1
$4.27M Sell
64,400
-21,760
-25% -$1.47M ﹤0.01% 1829
2013
Q4
$5.71M Buy
86,160
+160
+0.2% +$10.4K 0.01% 1711
2013
Q3
$5.38M Buy
86,000
+13,760
+19% +$886K 0.01% 1622
2013
Q2
$4.51M Buy
+72,240
New +$4.59M 0.01% 1708

Other funds holding GSK

Barclays's GSK Position: Q1 2026 in Review

Barclays increased its GSK (GSK) stake by 19,318% in Q1 2026, buying an estimated $20.5M and bringing the position to 380,397 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #1080.

Barclays first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $246M in Q1 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Barclays held 380,397 shares of GSK worth $21M as of Q1 2026.
  • Barclays bought 378,438 GSK shares in Q1 2026, an estimated $20.5M.
  • GSK made up 0.01% of Barclays's portfolio in Q1 2026, its #1080 holding.
  • Barclays first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Barclays's GSK position peaked at $246M in Q1 2015.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.